by Team Small News | Jul 12, 2025 | Cipla, Dr Reddy's, Lupin, Pfizer, Pharma
The Global Digoxin Market study, recently introduced by HTF MI, provides a comprehensive overview of the product and industry scope, as well as an in-depth analysis of the market outlook and status from 2025 to 2031. The market is segmented by key regions, including...
by Team Small News | Jul 2, 2025 | Dr Reddy's
Dr. Reddy’s Laboratories, a leading pharmaceutical company, is gearing up to face challenges in the US market, particularly in the fourth quarter of the current fiscal year. The company’s Chairman, K Satish Reddy, and Co-Chairman and Managing Director, GV...
by Team Small News | Jun 20, 2025 | Dr Reddy's
Alvotech, a global biopharmaceutical company, and Dr. Reddy’s Laboratories, a leading pharmaceutical company, have announced a partnership to develop a biosimilar for Pembrolizumab, a cancer drug used to treat various types of cancer, including melanoma, lung...
by Team Small News | Jun 17, 2025 | Dr Reddy's
Alvotech, a global biopharmaceutical company, has partnered with Dr. Reddy’s Laboratories, a leading pharmaceutical company, to develop a biosimilar for the cancer drug pembrolizumab. Pembrolizumab, marketed under the brand name Keytruda, is a monoclonal...
by Team Small News | Jun 16, 2025 | Dr Reddy's
In a significant breakthrough, the JR Puram police in Srikakulam have arrested a gang of eight individuals, including employees of top pharmaceutical firms, for stealing Semaglutide, a valuable anti-diabetic and weight-loss medicine, from Dr. Reddy’s...
by Team Small News | Jun 14, 2025 | Dr Reddy's
Alvotech, a global biotech company, and Dr. Reddy’s Laboratories, a leading pharmaceutical company, have announced a partnership to develop a biosimilar of Merck’s Keytruda (pembrolizumab) for the treatment of cancer. The partnership aims to bring a more...